FDA Inspection 1162959 — Bora Pharmaceuticals Injectables Inc
The FDA completed an inspection of Bora Pharmaceuticals Injectables Inc on Feb 18, 2022 in Baltimore, MD. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Feb 18, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Baltimore, MD (United States)